Is oral dydrogesterone equivalent to vaginal micronized progesterone for luteal phase support in women receiving oocyte donation? [PDF]
Lorillon M +7 more
europepmc +1 more source
Systematic use of long-acting intramuscular progesterone in addition to oral dydrogesterone as luteal phase support for single fresh blastocyst transfer: A pilot study. [PDF]
Simon V +7 more
europepmc +1 more source
A Roadmap for Advancing Women's Health in Disorders of the Gut‐Brain Interaction
ABSTRACT Disorders of the Gut‐Brain Interaction (DGBI) are highly prevalent conditions that all gastroenterologists encounter in clinical practice. Differences between men and women in the prevalence and symptom burden of DGBI have been well documented in numerous epidemiological and observational studies.
Madison R. Heath, Yuying Luo
wiley +1 more source
Does luteal phase support in MOH-IUI treatment improve cumulative live birth rates in couples with unexplained subfertility? Study protocol of the LUMO study: a centre, randomised, double-blind, controlled trial with cost-effectiveness analysis. [PDF]
Preesman E +6 more
europepmc +1 more source
Our results suggested that the difference in pregnancy outcomes between fresh and frozen embryo transfer is related to the peak estradiol level and embryo transfer stage. The cutoff values for peak estradiol level for performing freeze‐all strategy to improve pregnancy outcomes were different for cleavage‐stage and blastocyst‐stage embryo transfer ...
Dingying Zhao +12 more
wiley +1 more source
Premature timing of progesterone luteal phase support initiation did not negatively impact live birth rates in modified natural frozen thawed embryo transfer cycles. [PDF]
Jiang WJ, Sun ZG, Song JY.
europepmc +1 more source
Estrogen plus progesterone supplementation for luteal phase support in in vitro fertilization and embryo transfer [PDF]
S. Chen +5 more
openalex +1 more source
Sociodemographic and occupational risk factors for premenstrual mood disorders among female workers
Premenstrual mood disorders (PMDs) were reported by 44.2% of Japanese working women aged 20–44 years. Job‐related factors increased the risk. As PMDs and occupational conditions may interact bidirectionally, longitudinal research is essential to clarify whether workplace improvements reduce PMDs and whether treatment enhances women's work ability ...
Mariko Shimoda +2 more
wiley +1 more source

